Researchers at the University of Georgia and Sanofi Pasteur, the vaccines division of Sanofi, announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.
They published their findings recently in the Journal of Virology.
Researchers from UGA and Sanofi Pasteur, which has a research and development collaboration agreement with UGA, will present their data tomorrow, March 30, at the World Vaccine Congress US 2016 in Washington, D.C.
“One of the problems with current influenza vaccines is that we have to make predictions about which virus strains will be most prevalent every year and build our vaccines around those predictions,” said Ted Ross, director of UGA’s Center for Vaccines and Immunology and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine. “What we have developed is a vaccine that protects against multiple different strains of H1N1 virus at once, so we might be able to one day replace the current standard of care with this more broadly cross-protective vaccine.”
The H1N1 influenza virus caused a worldwide pandemic in 2009. When it was first detected, it was called swine flu because the virus was similar to those found in pigs, but the virus now circulates as a seasonal form of influenza.
Using a technique called Computationally Optimized Broadly Reactive Antigen, or COBRA, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley, along with Ross, created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.
The COBRA vaccines were designed to recognize H1N1 viruses isolated within the last 100 years, but many of the experimental vaccines produced immunity against influenza strains not included in the design. This means that scientists may be able to produce a vaccine that not only protects against recognized seasonal and pandemic influenza strains, but also strains that have yet to be discovered.
Because this vaccine is generated from the genetic sequences of multiple flu viruses, it may protect against many strains over several years, Ross said. That would also allow for year-round manufacturing of the vaccine, since scientists would not have to halt production every year to identify the most prevalent strains.
This research is part of a broader effort to create a universal influenza vaccine, which would protect against all strains of the virus.
“We still have some work to do before we get a truly universal flu vaccine,” Ross said. “But the COBRA vaccine we’ve developed for H1N1 virus subtypes is a major step in the right direction.”
Learn more: UGA, Sanofi Pasteur develop new vaccine for H1N1 influenza
The Latest on: Flu vaccine
[google_news title=”” keyword=”flu vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Flu vaccine
- ‘Vaccine fatigue’ sees flu jab rates drop at Nottinghamshire hospitalson May 5, 2024 at 1:09 am
Fewer than three in five NHS workers at Sherwood Forest Hospitals Trust in Nottinghamshire got the flu vaccine this winter. ‘Vaccine fatigue’ has been blamed as one reason the rate is going down, both ...
- 'Vaccine fatigue' blamed for drop in NHS staff uptake of flu jabon May 4, 2024 at 11:16 pm
Vaccine "fatigue" has been blamed for a drop in flu jab uptake among NHS workers at a Nottinghamshire trust. Fewer than three in five workers at Sherwood Forest Hospitals NHS Foundation Trust got the ...
- Breakthrough study identifies potential treatments for influenza-associated encephalopathyon May 4, 2024 at 10:11 pm
It might start simply, with a cough or sneeze…but in some cases, the flu virus can make its way to your brain, causing serious symptoms or even death through a disease known as influenza-associated ...
- Will Cow Influenza Testing Affect Cattle Markets?on May 4, 2024 at 9:00 am
USDA’s new influenza testing rules add a step to transporting dairy cows across state lines, but it’s not clear if the cattle market will be affected.
- Launching an effective bird flu vaccine quickly could be tough, scientists warnon May 3, 2024 at 2:00 am
Federal health officials say the U.S. has the building blocks to make a vaccine to protect humans from bird flu, if needed. But experts warn we're nowhere near prepared for another pandemic.
- New vaccine approach shows promise in targeting less variable region of influenza viruson May 2, 2024 at 12:53 pm
Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable ...
- No More Yearly Flu Shots? Vaccine Mixed From 80,000 Proteins Could Be The Keyon May 2, 2024 at 7:45 am
So far, it’s worked well in mice and ferrets – could we soon be looking at a human equivalent? Why do we need to get a flu vaccine every year? Seasonal flu is responsible for roughly half a million ...
- Influenza Newson May 1, 2024 at 5:00 pm
Mar. 1, 2024 — Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA ...
- Universal Flu Vaccine May No Longer Be a Long Shoton May 1, 2024 at 5:00 pm
A schematic diagram of the influenza virus, showing the surface proteins hemagglutinin (blue, peanut shaped) and neuraminidase (red, flower shaped), to which antibodies attach during an immune ...
- Unlocking Lifetime Flu Protection: Duke’s Innovative Vaccine Strategyon May 1, 2024 at 11:00 am
Experimental vaccine targets portions of the flu virus that don’t change. Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the ...
via Bing News